Adjuvant therapy in major salivary gland cancers: Analysis of 8,580 patients in the National Cancer Database
Head & Neck May 18, 2018
Cheraghlou S, et al. - Authors evaluated the relationship of chemotherapy and adjuvant treatment with survival and if this differed by stage or the presence of adverse features in patients with salivary gland cancers. They conducted a retrospective study of adult salivary gland cancer cases diagnosed from 2004 to 2013 in the National Cancer Data Base (NCDB). Findings suggested an association of adjuvant chemotherapy with improved survival for patients with adverse features, regardless of stage. Experts did not note any association of the addition of chemotherapy to the adjuvant treatment of patients with the late-stage disease with adverse features with improved outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries